Permanent intestinal failure

Indian Pediatrics

Volumn 45, Issue 9, 2008, Pages 753-763

  Goulet, Olivier ^a,b   Fusaro, Fabio ^a   Lacaille, Florence ^a   Sauvat, Frédérique ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Chronic intestinal pseudoobstruction; Citrulline; Congenital enteropathy; Intestinal failure; Intestinal transplantation; Liver transplantation; Parenteral nutrition; Short bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; CITRULLINE; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; HUMAN GROWTH HORMONE; INSULIN; PROBIOTIC AGENT; RECOMBINANT EPIDERMAL GROWTH FACTOR;

AMINO ACID BLOOD LEVEL; ANTIBIOTIC THERAPY; CHILDHOOD MORTALITY; CHRONIC INTESTINAL PSEUDO OBSTRUCTION SYNDROME; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLON AGANGLIONOSIS; DISEASE MARKER; ENTEROPATHY; HUMAN; INCIDENCE; INTESTINAL FAILURE; INTESTINE OBSTRUCTION; INTESTINE TRANSPLANTATION; INTRAHEPATIC CHOLESTASIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEDICAL LITERATURE; MORBIDITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT REFERRAL; PROGNOSIS; REVIEW; SHORT BOWEL SYNDROME; TREATMENT INDICATION;

BIOLOGICAL MARKERS; CITRULLINE; DIGESTIVE SYSTEM ABNORMALITIES; HUMANS; INTESTINAL DISEASES; INTESTINAL PSEUDO-OBSTRUCTION; INTESTINES; LIVER TRANSPLANTATION; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

EID: 51349129749     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Goulet O, Sauvat F. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care 2006; 9: 304-313.
2. Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Révillon Y, Jan D, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr 2007; 44: 347-353.
3. Goulet O, Ruemmele F. Causes and management of intestinal failure. Gastroenterol 2006;130: 516-528.
4. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: A marker of enterocyte mass in villous atrophyassociated small bowel disease. Gastroenterol 2003; 124: 1210-1219.
5. David AI, Gaynor JJ, Zis PP, Conanan L, Goldsmith L, Esquenazi V, et al. An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation. Transplant Proc 2006; 38: 1731-1732.
6. Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, et al. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res 2005; 127: 177-182.
7. Rhoads JM, Plunkett E, Galanko J, Lichtman S, Taylor L, Maynor A, et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 2005; 146: 542-547.
8. Koffeman GI, van Gemert WG, George EK, Veenendaal RA. Classification, epidemiology and aetiology. Best Pract Res Clin Gastroenterol 2003; 17: 879-893.
9. Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005; 15: 95-101.
10. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005; 40: 755-762.
11. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001; 139: 27-33.
12. Diamond IR, de Silva N, Pencharz PB, Kim JH, Wales PW; Group for the Improvement of Intestinal Function and Treatment. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg 2007; 42: 806-811.
13. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-196.
14. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
15. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369:1614-1620.
16. Quiros-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004;145 :157-163.
17. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005; 242: 403-409.
18. Jackson CS, Buchman AL. The nutritional management of short bowel syndrome. Nutr Clin Care 2004; 7: 114-121.
19. Mitchell JE, Breuer RI, Zuckerman L, Berlin J, Schilli R, Dunn JK. The colon influences ileal resection diarrhea. Dig Dis Sci 1980; 25: 33-41.
20. Puwanant M, Mo-Suwan L, Patrapinyokul S. Recurrent D-lactic acidosis in a child with short bowel syndrome. Asia Pac J Clin Nutr 2005; 14: 195-198.
21. Kaufman SS, Loseke CA, Lupo JV, Young RJ, Murray ND, Pinch LW, et al. Influence of bacterial overgrowth and intestinal inflammation on duration of PN in children with short bowel syndrome J Pediatr 1997: 131: 356-361.
22. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Dev Pediatr 2003; 50: 245-267.
23. Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal disease. Nutr Clin Pract2003; 18: 507-516.
24. Wales PW. Surgical therapy for short bowel syndrome. Pediatr Surg Int 2004; 20: 647-657.
25. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997; 90: 429-432.
26. DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol 2004; 99: 1823-1832.
27. Javid PJ, Kim HB, Duggan CP, Jaksic T. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg 2005; 40: 1019-1023.
28. Modi BP, Javid PJ, Jaksic T, Piper H, Langer M, Duggan C, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007; 204: 365-371.
29. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home PN-dependent short bowel patients: a positive study. Gastroenterology 2003; 124: 293-302.
30. Parekh NR, Steiger E. Criteria for the use of recombinant human growth hormone in short bowel syndrome. Nutr Clin Pract 2005; 20: 503-508.
31. Dabbas-Tyan M, Colomb V, Rosilio M, Landais P, Ricour C, Goulet O. Evaluation of the effect of recombinant human growth hormone (rhGH) treatment of children with short bowel syndrome. J Pediatr Gastroenterol Nutr 2000; 31: 5165-5166
32. Lifschitz C, Duggan C, Lazngston C, Vanderhoof J, Shulman RJ. Growth Hormone (GH) therapy in children with short bowel syndrome (SBS): a randomized, placebo controlled study. Digestive Disease Week; Orlando 2003: A100.
33. Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005; 54: 1224-1231.
34. Sigalet DL, Martin G, Meddings J, Hartman B, Hoist JJ. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 2004; 56: 371-376.
35. Iskit SH, Tugtepe H, Ayyildiz SH, Kotiloglu E, Dagli TE, Yegen BC. Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection. Pediatr Surg Int 2005; 21: 436-440.
36. Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 2005; 40: 763-768.
37. Sukhotnik I, Mogilner J, Shamir R, Shehadeh N, Bejar J, Hirsh M, Coran AG. Effect of subcutaneous insulin on intestinal adaptation in a rat model of short bowel syndrome. Pediatr Surg Int 2005; 21: 132-137.
38. Sukhotnik I, Shehadeh N, Shamir R, Bejar J, Bernshten A, Mogilner JG. Oral enhances intestinal re-growth following massive resection in rat. Dig DisSci 2005; 50: 2379-2385.
39. Sauvat F, Grimaldi C, Lacaille F, Ruemmele F, Dupic L, Bourdaud N, et al. Intestinal transplantation for total intestinal aganglionosis : A series of twelve consecutive children. J Pediatr Surg 2008 (in press).
40. Faure C, Goulet O, Ategbo S, Breton A, Tounian P, Ginies JL, et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome and prognosis in 105 children. Dig Dis Sci 1999; 44: 953-959.
41. Heneyke S, Smith W, Spitz L, Milla PJ. Chronic intestinal pseudo-obstruction : treatment and long term follow up of 44 patients. Arch Dis Child 1999; 81 : 21-27.
42. Loinaz C, Mittal N, Kato T, Miller B, Rodriguez M, Tzakis A. Multivisceral transplantation for pediatric intestinal pseudo-obstruction: single center's experience of 16 cases. Transplant Proc 2004; 36: 312-313.
43. Masetti M, Di Benedetto F, Cautero N, Stanghellini V, De Giorgio R, Lauro A, et al. Intestinal transplantation for chronic intestinal pseudoobstruction in adult patients. Am J Transplant 2004; 4: 826-829.
44. Ruemmele FM, Schmitz J, Goulet O. Microvillous inclusion disease (microvillous atrophy).Orphanet J Rare Dis 2006; 1: 22.
45. Goulet O, Kedinger M, Brousse N, Cuenod B, Colomb V, Patey N, et al. Intractable diarrhea of infancy: a new entity with epithelial and basement membrane abnormalities. J Pediatr 1995; 127 : 212-219.
46. Goulet O, Salomon J, Ruemmele F, Patey-Mariaud de Serres N, Brousse N. Intestinal epithelial dysplasia (Tufting enteropathy). Orphanet J Rare Dis 2007; 2: 20.
47. Randak C, Langnas AN, Kaufman SS, Phillips AD, Wisecarver JL, Hadorn HB, et al. Pretransplant management and small bowel-liver transplantation in an infant with microvillus inclusion disease. J Pediatr Gastroenterol Nutr 1998; 27:333-337.
48. Oliva MM, Perman JA, Saavedra JM, Young-Ramsaran J, Schwarz KB. Successful intestinal transplantation for microvillus inclusion disease. Gastroenterology 1994; 106 : 771-774.
49. Lacaille F, Cuenod B, Colomb V, Jan D, Canioni D, Revillon Y, et al. Successful combined liver and small bowel transplantation in a child with epithelial dysplasia. J Pediatr Gastroenterol Nutr 1998; 27: 230-233.
50. Goulet O, Sauvat F, Ruemmele F, Caldari D, Damotte D, Cezard JP, et al. Results of the Paris program: ten years of pediatric intestinal transplantation. Transplant Proc 2005; 37:1667-1670.
51. Ruemmele F, Jan D, Lacaile F, Cezard JP, Canioni D, Phillips AD, et al. New perspectives for children with microvillous inclusion disease: early small bowel transplantation. Transplantation 2004; 77: 1024-1028.
52. Ruemmele FM, Brousse N, Goulet O. Autoimmune enteropathy. In: Walker A, Goulet O, Kleinman R, Shneider P, Sherman P, Sanderson I. Pediatric Gastrointestinal Disease. Hamilton, Ontario, Canada: BcDecker Inc Publisher; 2004. p. 959-965.
53. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome. J Med Genet 2002; 39: 537-545.
54. Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O, et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005; 147: 256-259.
55. Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758-1762.
56. Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 2007; 132: 1705-1717.
57. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; for the Parenteral Nutrition Guidelines Working Group. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41: S1-S4.
58. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007; 44: 459-463.
59. Horslen SP, Sudan DL, Iyer KR, Kaufman SS, Iverson AK, Fox IJ, et al. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg 2002; 235: 435-439.
60. Botha JF, Grant WJ, Torres C, Iverson AK, Sudan DL, Shaw BW Jr, et al. Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl 2006; 12: 1062-1066.
61. Pironi L, Hébuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 2006; 101: 1633-1643.
62. American Gastroenterological Association Medical Position Statement. Short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 115-1110.
63. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111-1134.
64. Kaufman SS, Atkinson JB, Bianchi A, Goulet OJ, Grant D, Langnas AN, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transpl 2001; 5; 80-87.
65. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term PN in children. J Parenter Enteral Nutr 2000; 24: 345-350.
66. Bueno J, Ohwada S, Kocoshis S, Mazariegos GV, Dvorchik I, Sigurdsson L, et al. Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999; 34: 27-33.
67. Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl 2003; 9: 748-753.
68. Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, et al.; Intestine Transplant Registry. 2003 report of the Intestine Transplant Registry : a new era has dawned. Ann Surg 2005; 241: 607-613.
69. Sauvat F, Dupic L, Caldari D, Lesage F, Cézard JP, Lacaille F, et al. Factors influencing outcome after intestinal transplantation in children. Transplant Proc 2006; 38: 1689-1691.
70. Lloyd DA, Vega R, Bassett P, Forbes A, Gabe SM. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther 2006; 24: 1231-1240.
71. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN). Home parenteral nutrition in children. J Pediatr Gastroenterol Nutr 2005; 41 Suppl 2, S70-S75.
72. Chungfat N, Dixler I, Cohran V, Buchman A, Abecassis M, Fryer J. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 2007; 205: 755-761.
73. Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007; 45: 204-212.
74. Lopushinsky SR, Fowler RA, Kulkarni GS, Fecteau AH, Grant DR, Wales PW. The optimal timing of intestinal transplantation for children with intestinal failure: a Markov analysis. Ann Surg 2007; 246:1092-1099.
75. Nucci A, Cartland Burns R, Armah T, Lowery K, Yaworski JA, Strohm S, et al. Interdisciplinary Management of Pediatric Intestinal Failure: A 10-Year Review of Rehabilitation and Transplantation. J Gastrointest Surg 2008; 12: 429-436.
76. Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology 2006; 130: S132-137.
77. Venick RS, Farmer DG, Saikali D, Gordon S, Colangelo J, Reyen L, et al. Nutritional outcomes following pediatric intestinal transplantation. Transplant Proc 2006; 38:1718-1719.
78. Ueno T, Kato T, Revas K, Gaynor J, Velasco M, Selvaggi G, et al. Nutritional status after intestinal transplantation in children. Eur J Pediatr Surg 2006;16: 403-406.
79. Ueno T, Kato T, Revas K, Gaynor J, Velasco M, Selvaggi YO, et al. Growth after intestinal transplant in children. Transplant Proc 2006; 38: 1702-1704.
80. Lacaille F, Vass N, Sauvat F, Canioni D, Colomb V, Talbotec C, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut 2007; 57; 455-461.